These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33315748)

  • 21. Sexual behaviour, STI knowledge and Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) prevalence in an asymptomatic cohort in Ruhr-area, Germany: PreYoungGo study.
    Skaletz-Rorowski A; Potthoff A; Nambiar S; Wach J; Kayser A; Kasper A; Brockmeyer NH
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):241-246. PubMed ID: 32881091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonorrhea and chlamydia prevalence in different anatomical sites among men who have sex with men: a cross-sectional study in Guangzhou, China.
    Yang LG; Zhang XH; Zhao PZ; Chen ZY; Ke WJ; Ren XQ; Wang LY; Chen WY; Tucker JD
    BMC Infect Dis; 2018 Dec; 18(1):675. PubMed ID: 30563478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic.
    Clarivet B; Picot E; Marchandin H; Tribout V; Rachedi N; Schwartzentruber E; Ledésert B; Dereure O; Guillot B; Picot MC
    Eur J Dermatol; 2014; 24(5):611-6. PubMed ID: 25322708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of the effects of a brief intervention to increase chlamydia and gonorrhea testing uptake among young adult female emergency department patients.
    Baird J; Merchant RC
    Acad Emerg Med; 2014 Dec; 21(12):1512-20. PubMed ID: 25491714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Female users of internet-based screening for rectal STIs: descriptive statistics and correlates of positivity.
    Ladd J; Hsieh YH; Barnes M; Quinn N; Jett-Goheen M; Gaydos CA
    Sex Transm Infect; 2014 Sep; 90(6):485-90. PubMed ID: 24604333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study.
    Wynn A; Mussa A; Ryan R; Hansman E; Simon S; Bame B; Moreri-Ntshabele B; Ramogola-Masire D; Klausner JD; Morroni C
    BMC Infect Dis; 2022 Mar; 22(1):229. PubMed ID: 35255814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat Chlamydia trachomatis testing among heterosexual STI outpatient clinic visitors in the Netherlands: a longitudinal study.
    Visser M; van Aar F; Koedijk FDH; Kampman CJG; Heijne JCM
    BMC Infect Dis; 2017 Dec; 17(1):782. PubMed ID: 29262776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in an urban public hospital pregnancy termination clinic.
    Park J; Zimmerman L; Stempinski K; Bridge R; Roston A; Patel A
    Int J STD AIDS; 2017 Oct; 28(12):1164-1168. PubMed ID: 28114879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Where Do People Go for Gonorrhea and Chlamydia Tests: A Cross-Sectional View of the Central Indiana Population, 2003-2014.
    Batteiger TA; Dixon BE; Wang J; Zhang Z; Tao G; Tong Y; Tu W; Hoover SA; Arno JN
    Sex Transm Dis; 2019 Feb; 46(2):132-136. PubMed ID: 30334869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in chlamydia and gonorrhoeae positivity rate among heterosexual STI clinic visitors in the Netherlands: contribution of client and regional characteristics as assessed by cross-sectional surveillance data.
    Götz HM; van Oeffelen LA; Hoebe CJPA; van Benthem BH
    BMJ Open; 2019 Jan; 9(1):e022793. PubMed ID: 30670509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provider uptake of extragenital screening for gonorrhea and chlamydia in a cohort of Air Force members with incident HIV diagnosis.
    Yabes J; Lamb CC; Hakre S; Scott PT; Mika W; Okulicz JF
    Medicine (Baltimore); 2022 Oct; 101(42):e31209. PubMed ID: 36281093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal Screening for Sexually Transmitted Infections among Asymptomatic Adolescents in an Urban Emergency Department: High Acceptance but Low Prevalence of Infection.
    Goyal MK; Teach SJ; Badolato GM; Trent M; Chamberlain JM
    J Pediatr; 2016 Apr; 171():128-32. PubMed ID: 26846572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda.
    Nakku-Joloba E; Mboowa G; Ssengooba W; Kiyimba A; Kigozi E; Baluku H; Alinaitwe L; Nyote R; Kabahita JM; Mutumba P; Katabazi FA; Kiwanuka N; Sewankambo N; Kateete DP
    Afr Health Sci; 2022 Sep; 22(3):62-71. PubMed ID: 36910377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic.
    De Baetselier I; Apers L; Platteau T; Buyze J; Florence E; Kenyon C; Van den Bossche D;
    Int J STD AIDS; 2021 Oct; 32(11):998-1003. PubMed ID: 34096386
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of Sexually Transmitted Infection Screening for Adolescents and Young Adults in the Pediatric Emergency Department.
    Eckman MH; Reed JL; Trent M; Goyal MK
    JAMA Pediatr; 2021 Jan; 175(1):81-89. PubMed ID: 33136149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection.
    Braun DL; Marzel A; Steffens D; Schreiber PW; Grube C; Scherrer AU; Kouyos RD; Günthard HF;
    Clin Infect Dis; 2018 Feb; 66(5):735-742. PubMed ID: 29028966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Chlamydia trachomatis infection: application of a scoring rule to other populations.
    Götz HM; Veldhuijzen IK; Habbema JD; Boeke AJ; Richardus JH; Steyerberg EW
    Sex Transm Dis; 2006 Jun; 33(6):374-80. PubMed ID: 16505746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study.
    van Liere GA; Dukers-Muijrers NH; van Bergen JE; Götz HM; Stals F; Hoebe CJ
    BMC Infect Dis; 2014 Nov; 14():612. PubMed ID: 25403312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.